VenlafaxineisaninhibitoroftheSEROtonintransporter(SERT),norepinephrinetransporter(NET),andmonoamineoxidase(MAO).Venlafaxineexhibitsantidepressant,analgesic,andneuroprotectiveactivities.Venlafaxinedecreasespaininanimalmodelsofdiabeticneuropathyandimprovescognitiveperformanceanddecreasesoxidativestressparametersin3-NP-treatedanimalmodelsofHuntington’sdisease.
| CasNo. | 99300-78-4 |
|---|---|
| Purity | ≥98% |
| Formula | C17H27NO2•HCl |
| FormulaWt. | 313.87 |
| ChemicalName | 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-cyclohexanolhydrochloride |
| IUPACName | 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol;hydrochloride |
| Synonym | Effexor;HSDB6699;Wy45030 |
| MeltingPoint | 215-217°C |
| Solubility | Solubleinwater. |
| Appearance | WhiteCrystalPowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| MSDS | V1854MSDSPDF |
|---|---|
| InfoSheet | V1854InfoSheetPDF |
VidalR,DiazA,PazosA,etal.Region-specificregulationof5-HT1Breceptorsintheratbrainbychronicvenlafaxinetreatment.Psychopharmacology(Berl).2013Sep;229(1):177-85.PMID:23609771.
Cegielska-PerunK,Bujalska-ZadrożnyM,TatarkiewiczJ,etal.Venlafaxineandneuropathicpain.Pharmacology.2013;91(1-2):69-76.PMID:23183148.
FisarZ,HroudováJ,RabochJ.InhibitionofmonoamineoxidaseactivitybyantidepressantsandmoodstABIlizers.NeuroEndocrinolLett.2010;31(5):645-56.PMID:21200377.
KumarP,KaloniaH,KumarA.Nitricoxidemechanismintheprotectiveeffectofantidepressantsagainst3-nitropropionicacid-inducedcognitivedeficit,glutathioneandmitochondrialalterationsinanimalmodelofHuntington"sdisease.BehavPharmacol.2010May;21(3):217-30.PMID:20480544.
